Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kranz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Bioinformatics|April 17, 2026
Automated deep learning based detection of cellular deposits on clinically used ECMO membrane lungsDaniel Pointner, Michael Kranz, Maria Stella Wagner, et al.
Advanced Synthesis & Catalysis|October 8, 2009
Studies on the Bisoxazoline and (-)-Sparteine Mediated Enantioselective Addition of Organolithium Reagents to IminesScott E Denmark, Noriyuki Nakajima, Cory M Stiff, et al.
Regulatory Toxicology and Pharmacology : RTP|December 28, 2014
Evaluation of aromatic amines with different purities and different solvent vehicles in the Ames testAlexander P Harding, Paul L A Popelier, James Harvey, et al.
Frontiers in Cardiovascular Medicine|February 20, 2026
Polymer embedding of membrane lungs for histological investigations of intra-device clot formationMichael Kranz, Maria Stella Wagner, Daniel Pointner, et al.
Frontiers in Medicine|July 4, 2024
Computer based visualization of clot structures in extracorporeal membrane oxygenation and histological clot investigations for understanding thrombosis in membrane lungsMaria S Wagner, Michael Kranz, Lars Krenkel, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|December 13, 2005
Solution, solid phase and computational structures of apicidin and its backbone-reduced analogsMichael Kranz, Peter John Murray, Stephen Taylor, et al.
Bioorganic & Medicinal Chemistry|June 16, 2009
Identification of PDE4B Over 4D subtype-selective inhibitors revealing an unprecedented binding modeMichael Kranz, Michael Wall, Brian Evans, et al.
Nature Structural & Molecular Biology|August 31, 2010
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistanceAlexandre Wohlkonig, Pan F Chan, Andrew P Fosberry, et al.
Journal of Chemical Information and Modeling|May 7, 2016
CSAR 2014: A Benchmark Exercise Using Unpublished Data from PharmaHeather A Carlson, Richard D Smith, Kelly L Damm-Ganamet, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administrationChristopher J Lunniss, Anthony W J Cooper, Colin D Eldred, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Bioinformatics|April 17, 2026
Automated deep learning based detection of cellular deposits on clinically used ECMO membrane lungsDaniel Pointner, Michael Kranz, Maria Stella Wagner, et al.
Advanced Synthesis & Catalysis|October 8, 2009
Studies on the Bisoxazoline and (-)-Sparteine Mediated Enantioselective Addition of Organolithium Reagents to IminesScott E Denmark, Noriyuki Nakajima, Cory M Stiff, et al.
Regulatory Toxicology and Pharmacology : RTP|December 28, 2014
Evaluation of aromatic amines with different purities and different solvent vehicles in the Ames testAlexander P Harding, Paul L A Popelier, James Harvey, et al.
Frontiers in Cardiovascular Medicine|February 20, 2026
Polymer embedding of membrane lungs for histological investigations of intra-device clot formationMichael Kranz, Maria Stella Wagner, Daniel Pointner, et al.
Frontiers in Medicine|July 4, 2024
Computer based visualization of clot structures in extracorporeal membrane oxygenation and histological clot investigations for understanding thrombosis in membrane lungsMaria S Wagner, Michael Kranz, Lars Krenkel, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|December 13, 2005
Solution, solid phase and computational structures of apicidin and its backbone-reduced analogsMichael Kranz, Peter John Murray, Stephen Taylor, et al.
Bioorganic & Medicinal Chemistry|June 16, 2009
Identification of PDE4B Over 4D subtype-selective inhibitors revealing an unprecedented binding modeMichael Kranz, Michael Wall, Brian Evans, et al.
Nature Structural & Molecular Biology|August 31, 2010
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistanceAlexandre Wohlkonig, Pan F Chan, Andrew P Fosberry, et al.
Journal of Chemical Information and Modeling|May 7, 2016
CSAR 2014: A Benchmark Exercise Using Unpublished Data from PharmaHeather A Carlson, Richard D Smith, Kelly L Damm-Ganamet, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administrationChristopher J Lunniss, Anthony W J Cooper, Colin D Eldred, et al.
Pageof 2